103 Effect of a single Revalor-XH or Revalor-200/Revalor-200 re-implant program and zinc supplementation on performance, carcass characteristics, and liver mineral of feedlot heifers

Abstract

Abstract A 169-d study utilizing 208 Angus-cross heifers (291 ± 23 kg; 4 sources) in a 2×2 factorial examined the effects of implant strategy and Zn supplementation on growth and mineral status of heifers. Factors included 2 implant (Merck Animal Health, Madison, NJ) strategies: extended-release Revalor-XH on d 0 (REV-XH; 20 mg estradiol+200 mg trenbolone acetate) or Revalor-200 on d 0 and 91 (REV-200; 20 mg estradiol+200 mg trenbolone acetate) and 2 supplemental Zn (mg/kg dry matter [DM]; ZnSO4) strategies: national (30; NRC) or industry (100; IND) recommendations. Heifers were blocked by weight within source (n = 5 or 6 heifers/pen; 9 pens/treatment), received a corn silage-based diet (d 0-56), then transitioned to a corn-based diet fed via concrete bunks. Data were analyzed in Proc Mixed of SAS; fixed effects of implant (IMP), Zn, interaction, and source with the repeated effect of time for average daily gain (ADG) and liver mineral. Initial weight served as a covariate for performance and carcass data. Revalor-200 had greater ADG from d 0-28 and 91-120, while REV-XH peaked during d 56-91 (IMP × time; P = 0.02), corresponding to likely periods of greatest hormone payout from each implant. Liver Mn concentrations decreased on d 14 regardless of implant while d 105 and 164 concentrations were lesser for REV-200 (IMP × time; P = 0.02). Hot carcass weight, DM intake, carcass-adjusted ADG and feed efficiency were not different between IMP strategies (P ≥ 0.18). Steers fed IND tended to be heavier on d 91 (P = 0.06) and were heavier on d 120 (P = 0.05) than NRC; however, final BW did not differ due to Zn (P = 0.37). The similar performance between implant strategies and superior performance during peak hormone payout by heifers supplemented IND vs. NRC suggests increased Zn may support rapid growth.